KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Receivables (2016 - 2025)

Novartis Ag's Receivables history spans 14 years, with the latest figure at $10.1 billion for Q4 2025.

  • On a quarterly basis, Receivables rose 18.29% to $10.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.1 billion, a 18.29% increase, with the full-year FY2025 number at $10.1 billion, up 18.29% from a year prior.
  • Receivables hit $10.1 billion in Q4 2025 for Novartis Ag, up from $9.1 billion in the prior quarter.
  • Over the last five years, Receivables for NVS hit a ceiling of $10.1 billion in Q4 2025 and a floor of $8.2 billion in Q2 2024.
  • Historically, Receivables has averaged $8.8 billion across 5 years, with a median of $8.7 billion in 2021.
  • Biggest five-year swings in Receivables: decreased 10.52% in 2024 and later grew 18.29% in 2025.
  • Tracing NVS's Receivables over 5 years: stood at $8.8 billion in 2021, then grew by 2.57% to $9.0 billion in 2022, then dropped by 7.37% to $8.4 billion in 2023, then increased by 1.93% to $8.5 billion in 2024, then increased by 18.29% to $10.1 billion in 2025.
  • Business Quant data shows Receivables for NVS at $10.1 billion in Q4 2025, $9.1 billion in Q2 2025, and $8.5 billion in Q4 2024.